Article Details

BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update

Retrieved on: 2024-08-01 19:54:50

Tags for this article:

Click the tags to see associated articles and topics

BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update. View article details on hiswai:

Excerpt

... investments in equity securities of $63.2 million, and special cash dividends received from investments in equity securities of $25.7 million.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up